Respiratory · Inhalation
budesonide / formoterol · 160/4.5 mcg
Symbicort is a combination inhaler containing budesonide and formoterol. It helps prevent and control symptoms of asthma and chronic obstructive pulmonary disease. Patients should rinse the mouth after each use to reduce the risk of oral thrush. The dose must be individualised by the prescribing clinician.
Budesonide is an inhaled corticosteroid with potent anti-inflammatory activity. Formoterol is a long-acting beta2-agonist that produces bronchodilation. The combination provides both maintenance and reliever therapy.
Asthma and COPD maintenance treatment in adults and adolescents.
Two inhalations twice daily. Additional inhalations may be used for symptom relief.
Paradoxical bronchospasm, candida infections and pneumonia in COPD patients possible. Use with caution in severe cardiovascular disorders.
Rinse mouth after use. Not for acute bronchospasm.
Beta-blockers may antagonise formoterol; ketoconazole may increase budesonide exposure.
Store below 30°C with mouthpiece cover on.
This product information is provided for educational purposes only and is not a substitute for professional medical advice.
